Back

Restoration of Gamma Center Frequency via Personalized Entrainment Marks Cognitive Preservation in Early Alzheimer's Disease

Park, Y.; Chae, H.; Yoon, E.; Kim, Y.; Han, J. W.; Woo, S. J.; Yoo, S.; Kim, K. W.

2026-01-28 psychiatry and clinical psychology
10.64898/2026.01.23.26344352 medRxiv
Show abstract

BackgroundGamma entrainment shows promise for Alzheimers disease (AD) treatment in preclinical models, but human trials have yielded heterogeneous results. We hypothesized that the clinical efficacy of gamma entrainment depends on individual neurophysiological receptivity, specifically the capacity for neural circuit plasticity. MethodsIn this open-label pilot study, we screened 37 individuals and enrolled 16 participants with early AD (CDR 0.5-1.0, amyloid-positive) who completed 12 weeks of home-based flickering light stimulation at individually optimized gamma frequencies (32-40 Hz). Pre- and post-intervention assessments included 64-channel EEG recordings and MMSE. ResultsParticipants demonstrated dichotomous neurophysiological responses: 43.8% showed CF increase (ICF+) while 56.3% showed no change/decrease (ICF-). CF restoration was significantly associated with cognitive preservation (r=0.52, p=0.039). Notably, future responders exhibited distinct baseline signatures of "neural reserve," characterized by higher temporal gamma power (Cohens d=0.70-0.92) and stronger frontotemporal connectivity (Cohens d=1.11-1.47). Almost 30% of screened candidates failed to show baseline entrainment, highlighting a distinct "non-responsive" biological subtype. DiscussionCF restoration following personalized gamma entrainment identifies a neurophysiological subtype capable of meaningful plasticity. Rather than a universal remedy, gamma entrainment appears to act on specific neural substrates preserved in a subset of patients. These findings suggest that baseline electrophysiological profiling could unlock gamma entrainments therapeutic potential by stratifying likely responders for precision neuromodulation.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Alzheimer's & Dementia
143 papers in training set
Top 0.4%
18.2%
2
Alzheimer's Research & Therapy
52 papers in training set
Top 0.1%
9.9%
3
Journal of Neurology, Neurosurgery & Psychiatry
29 papers in training set
Top 0.1%
9.9%
4
NeuroImage: Clinical
132 papers in training set
Top 0.5%
8.2%
5
Alzheimer's & Dementia: Translational Research & Clinical Interventions
16 papers in training set
Top 0.1%
3.5%
6
Neurobiology of Disease
134 papers in training set
Top 2%
3.5%
50% of probability mass above
7
Molecular Psychiatry
242 papers in training set
Top 1.0%
3.5%
8
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
38 papers in training set
Top 0.5%
3.2%
9
Nature Communications
4913 papers in training set
Top 43%
3.0%
10
Frontiers in Aging Neuroscience
67 papers in training set
Top 1%
2.7%
11
eBioMedicine
130 papers in training set
Top 0.6%
2.5%
12
Journal of Alzheimer's Disease
43 papers in training set
Top 0.6%
2.5%
13
Translational Psychiatry
219 papers in training set
Top 2%
2.5%
14
Brain Communications
147 papers in training set
Top 2%
1.7%
15
Imaging Neuroscience
242 papers in training set
Top 2%
1.7%
16
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.9%
1.7%
17
Journal of Alzheimer’s Disease
39 papers in training set
Top 0.6%
1.6%
18
Brain Stimulation
112 papers in training set
Top 1%
1.3%
19
Neurology
44 papers in training set
Top 1%
1.2%
20
Scientific Reports
3102 papers in training set
Top 70%
0.9%
21
PLOS ONE
4510 papers in training set
Top 65%
0.9%
22
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.4%
0.7%
23
Annals of Neurology
57 papers in training set
Top 2%
0.7%
24
Brain, Behavior, and Immunity
105 papers in training set
Top 3%
0.6%
25
Neurology Genetics
14 papers in training set
Top 0.4%
0.6%